Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Knight

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Open Biology|November 22, 2013
Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activityJohn R P Knight, Simon J Allison, Jo Milner
Nucleic Acids Research|March 7, 2013
Active regulator of SIRT1 is required for ribosome biogenesis and functionJohn R P Knight, Anne E Willis, Jo Milner
Emerging Topics in Life Sciences|December 8, 2025
Causes and consequences of RNA:protein cross-links - lessons from chemotherapyZornitsa Vasileva Kotopanova, Eloise Wilkinson, Zijian Zhang, et al.
The Biochemical Journal|October 21, 2014
p58IPK is an inhibitor of the eIF2α kinase GCN2 and its localization and expression underpin protein synthesis and ER processing capacityAnne Roobol, Jo Roobol, Amandine Bastide, et al.
Cell Cycle (Georgetown, Tex.)|February 7, 2015
Transient association of MCM complex proteins with the nuclear matrix during initiation of mammalian DNA replicationEmma L Hesketh, John R P Knight, Rosemary H C Wilson, et al.
Molecular and Cellular Biology|July 30, 2017
Correction for Shah et al., "A Deacetylase-Deficient SIRT1 Variant Opposes Full-Length SIRT1 in Regulating Tumor Suppressor p53 and Governs Expression of Cancer-Related Genes"Zahid H Shah, Shafiq U Ahmed, Jack R Ford, et al.
Oncogenesis|May 14, 2014
Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathwaysS J Allison, J R P Knight, C Granchi, et al.
Molecular and Cellular Biology|November 30, 2011
A deacetylase-deficient SIRT1 variant opposes full-length SIRT1 in regulating tumor suppressor p53 and governs expression of cancer-related genesZahid H Shah, Shafiq U Ahmed, Jack R Ford, et al.
Journal of Cell Science|January 14, 2021
Translation initiation in cancer at a glanceRachael C L Smith, Georgios Kanellos, Nikola Vlahov, et al.
RNA (New York, N.Y.)|February 10, 2016
Cooling-induced SUMOylation of EXOSC10 down-regulates ribosome biogenesisJohn R P Knight, Amandine Bastide, Diego Peretti, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Open Biology|November 22, 2013
Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 activityJohn R P Knight, Simon J Allison, Jo Milner
Nucleic Acids Research|March 7, 2013
Active regulator of SIRT1 is required for ribosome biogenesis and functionJohn R P Knight, Anne E Willis, Jo Milner
Emerging Topics in Life Sciences|December 8, 2025
Causes and consequences of RNA:protein cross-links - lessons from chemotherapyZornitsa Vasileva Kotopanova, Eloise Wilkinson, Zijian Zhang, et al.
The Biochemical Journal|October 21, 2014
p58IPK is an inhibitor of the eIF2α kinase GCN2 and its localization and expression underpin protein synthesis and ER processing capacityAnne Roobol, Jo Roobol, Amandine Bastide, et al.
Cell Cycle (Georgetown, Tex.)|February 7, 2015
Transient association of MCM complex proteins with the nuclear matrix during initiation of mammalian DNA replicationEmma L Hesketh, John R P Knight, Rosemary H C Wilson, et al.
Molecular and Cellular Biology|July 30, 2017
Correction for Shah et al., "A Deacetylase-Deficient SIRT1 Variant Opposes Full-Length SIRT1 in Regulating Tumor Suppressor p53 and Governs Expression of Cancer-Related Genes"Zahid H Shah, Shafiq U Ahmed, Jack R Ford, et al.
Oncogenesis|May 14, 2014
Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathwaysS J Allison, J R P Knight, C Granchi, et al.
Molecular and Cellular Biology|November 30, 2011
A deacetylase-deficient SIRT1 variant opposes full-length SIRT1 in regulating tumor suppressor p53 and governs expression of cancer-related genesZahid H Shah, Shafiq U Ahmed, Jack R Ford, et al.
Journal of Cell Science|January 14, 2021
Translation initiation in cancer at a glanceRachael C L Smith, Georgios Kanellos, Nikola Vlahov, et al.
RNA (New York, N.Y.)|February 10, 2016
Cooling-induced SUMOylation of EXOSC10 down-regulates ribosome biogenesisJohn R P Knight, Amandine Bastide, Diego Peretti, et al.
Pageof 4